Literature DB >> 27197569

Adenovirus infection among allogeneic stem cell transplant recipients.

Hugo César Pereira Santos1, Tâmera Nunes Vieira Almeida1, Fabíola Souza Fiaccadori1, Divina das Dôres de Paula Cardoso1, Adriano de Moraes Arantes2, Hugo Delleon da Silva3, Patricia Resende Alo Nagib4, Menira Souza1.   

Abstract

The human adenovirus (HAdV) infection can cause severe disease in immunocompromised patients, such as those undergoing allogeneic hematopoietic stem cell transplant (ASCT). The main objective of this study was to prospectively monitor ASCT recipients for HAdV occurrence in a reference center in Brazil, and also to correlate viral positivity, viral load, molecular variant, clinical symptoms, and patients' prognosis. From October/2012 to October/2014, blood and feces of 21 ASCT recipients were screened for HAdV by Nested-PCR. Viral loads were determined by real-time PCR. In total, 57% of the patients had at least one positive sample (serum or feces) for HAdV. Patients presented significantly higher viral load in feces when compared to serum. Positive samples were characterized as HAdVs of species HAdV-C, -D, and -F. The main clinical symptom presented by infected patients was diarrhea, and Graft-versus-host disease (GVHD) was the main intercurrence. An association was observed between HAdV-positivity and diarrhea and also between HAdV-positivity and GVHD. Results from this study may contribute to a better understanding of the HAdV infection pattern in patients submitted to ASCT. Data therein highlight the importance of including HAdV testing during all routine laboratory exams performed on ASCT patients. J. Med. Virol. 89:298-303, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  adenovirus; blood; transplantation; viral excretion

Mesh:

Year:  2016        PMID: 27197569     DOI: 10.1002/jmv.24579

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.

Authors:  Juliana Moura Nabarrete; Andrea Z Pereira; Adriana Garófolo; Adriana Seber; Angela Mandelli Venancio; Carlos Eduardo Setanni Grecco; Carmem Maria Sales Bonfim; Claudia Harumi Nakamura; Daieni Fernandes; Denise Johnsson Campos; Fernanda Luisa Ceragioli Oliveira; Flávia Krüger Cousseiro; Flávia Feijó Panico Rossi; Jocemara Gurmini; Karina Helena Canton Viani; Luciana Fernandes Guterres; Luiz Fernando Alves Lima Mantovani; Luiz Guilherme Darrigo Junior; Maria Isabel Brandão Pires E Albuquerque; Melina Brumatti; Mirella Aparecida Neves; Natália Duran; Neysimelia Costa Villela; Victor Gottardello Zecchin; Juliana Folloni Fernandes
Journal:  Einstein (Sao Paulo)       Date:  2021-12-10

2.  Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.

Authors:  Jeremy D Rubinstein; Xiang Zhu; Thomas Leemhuis; Giang Pham; Lorraine Ray; Sana Emberesh; Sonata Jodele; Shawn Thomas; Jose A Cancelas; Catherine M Bollard; Patrick J Hanley; Michael D Keller; Olivia Grimley; Diana Clark; Teri Clark; Cecilia S Lindestam Arlehamn; Alessandro Sette; Stella M Davies; Adam S Nelson; Michael S Grimley; Carolyn Lutzko
Journal:  Blood Adv       Date:  2021-09-14

Review 3.  Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.

Authors:  Xin Wang; Shyam A Patel; Michael Haddadin; Jan Cerny
Journal:  Ther Adv Infect Dis       Date:  2021-05-24

Review 4.  Intestinal HAdV Infection: Tissue Specificity, Persistence, and Implications for Antiviral Therapy.

Authors:  Karin Kosulin
Journal:  Viruses       Date:  2019-08-30       Impact factor: 5.048

5.  Epstein-Barr Virus Encephalitis and Disseminated Adenovirus Infection after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for a Patient with Ph-Like Acute Lymphoblastic Leukemia.

Authors:  Xiao Zhou; Xianmin Song; Liping Wan
Journal:  Case Rep Oncol       Date:  2022-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.